ResMed, Inc. Share Price

Equities

RMD

US7611521078

Advanced Medical Equipment & Technology

Market Closed - Nyse 01:30:02 18/07/2024 am IST 5-day change 1st Jan Change
206 USD -0.41% Intraday chart for ResMed, Inc. +7.08% +19.72%
Sales 2024 * 467.74Cr 39TCr Sales 2025 * 503.47Cr 42TCr Capitalization 3.04TCr 2,53800Cr
Net income 2024 * 102.3Cr 8.55TCr Net income 2025 * 123.8Cr 10TCr EV / Sales 2024 * 6.62 x
Net Debt 2024 * 61Cr 5.05TCr Net cash position 2025 * 33Cr 2.78TCr EV / Sales 2025 * 5.97 x
P/E ratio 2024 *
29.8 x
P/E ratio 2025 *
25.1 x
Employees 10,140
Yield 2024 *
0.95%
Yield 2025 *
1.04%
Free-Float 76.99%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.41%
1 week+7.08%
Current month+7.59%
1 month-2.09%
3 months+18.48%
6 months+20.64%
Current year+19.72%
More quotes
1 week
195.00
Extreme 195
208.83
1 month
179.42
Extreme 179.42
214.97
Current year
164.12
Extreme 164.1225
222.96
1 year
132.24
Extreme 132.24
229.97
3 years
132.24
Extreme 132.24
301.34
5 years
108.85
Extreme 108.85
301.34
10 years
45.74
Extreme 45.74
301.34
More quotes
Managers TitleAgeSince
Chief Executive Officer 51 01/00/01
Founder 81 01/89/01
Director of Finance/CFO 57 01/98/01
Members of the board TitleAgeSince
Chief Executive Officer 51 01/00/01
Director/Board Member 76 01/05/01
Founder 81 01/89/01
More insiders
Date Price Change Volume
18/24/18 206 -0.41% 692 901
16/24/16 206.8 +0.73% 738,637
15/24/15 205.3 +0.23% 1,387,329
12/24/12 204.8 +2.53% 753,610
11/24/11 199.8 +3.87% 694,774

Delayed Quote Nyse, July 18, 2024 at 01:30 am IST

More quotes
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows: - medical devices (50.4%); - masks (37.9%); - software as a service (11.7%). At the end of June 2021, the group had 6 production sites located in the United States (2), Australia, China, Singapore and Malaysia. The United States accounts for 61.4% of net sales.
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
206.8 USD
Average target price
220.9 USD
Spread / Average Target
+6.81%
Consensus